Logo image of TECH

BIO-TECHNE CORP (TECH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TECH - US09073M1045 - Common Stock

63.82 USD
+0.87 (+1.38%)
Last: 12/3/2025, 8:00:01 PM
63.82 USD
0 (0%)
After Hours: 12/3/2025, 8:00:01 PM
Fundamental Rating

6

Taking everything into account, TECH scores 6 out of 10 in our fundamental rating. TECH was compared to 58 industry peers in the Life Sciences Tools & Services industry. TECH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. TECH has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

TECH had positive earnings in the past year.
In the past year TECH had a positive cash flow from operations.
Each year in the past 5 years TECH has been profitable.
TECH had a positive operating cash flow in each of the past 5 years.
TECH Yearly Net Income VS EBIT VS OCF VS FCFTECH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

With a decent Return On Assets value of 3.04%, TECH is doing good in the industry, outperforming 74.14% of the companies in the same industry.
TECH's Return On Equity of 3.91% is fine compared to the rest of the industry. TECH outperforms 74.14% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.33%, TECH belongs to the top of the industry, outperforming 84.48% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for TECH is below the industry average of 13.53%.
The last Return On Invested Capital (9.33%) for TECH is above the 3 year average (9.00%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.04%
ROE 3.91%
ROIC 9.33%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
TECH Yearly ROA, ROE, ROICTECH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

TECH has a Profit Margin of 6.32%. This is in the better half of the industry: TECH outperforms 74.14% of its industry peers.
In the last couple of years the Profit Margin of TECH has declined.
TECH has a Operating Margin of 22.13%. This is amongst the best in the industry. TECH outperforms 91.38% of its industry peers.
In the last couple of years the Operating Margin of TECH has remained more or less at the same level.
Looking at the Gross Margin, with a value of 66.83%, TECH belongs to the top of the industry, outperforming 89.66% of the companies in the same industry.
TECH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.13%
PM (TTM) 6.32%
GM 66.83%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
TECH Yearly Profit, Operating, Gross MarginsTECH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TECH is destroying value.
The number of shares outstanding for TECH has been reduced compared to 1 year ago.
TECH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, TECH has a worse debt to assets ratio.
TECH Yearly Shares OutstandingTECH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
TECH Yearly Total Debt VS Total AssetsTECH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 12.16 indicates that TECH is not in any danger for bankruptcy at the moment.
TECH has a better Altman-Z score (12.16) than 96.55% of its industry peers.
The Debt to FCF ratio of TECH is 1.34, which is an excellent value as it means it would take TECH, only 1.34 years of fcf income to pay off all of its debts.
TECH has a better Debt to FCF ratio (1.34) than 89.66% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that TECH is not too dependend on debt financing.
The Debt to Equity ratio of TECH (0.15) is better than 62.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.34
Altman-Z 12.16
ROIC/WACC0.92
WACC10.16%
TECH Yearly LT Debt VS Equity VS FCFTECH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 4.22 indicates that TECH has no problem at all paying its short term obligations.
TECH has a Current ratio of 4.22. This is in the better half of the industry: TECH outperforms 65.52% of its industry peers.
A Quick Ratio of 2.81 indicates that TECH has no problem at all paying its short term obligations.
TECH has a Quick ratio (2.81) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.22
Quick Ratio 2.81
TECH Yearly Current Assets VS Current LiabilitesTECH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.82% over the past year.
The Earnings Per Share has been growing by 11.25% on average over the past years. This is quite good.
TECH shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.00%.
The Revenue has been growing by 10.55% on average over the past years. This is quite good.
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%

3.2 Future

The Earnings Per Share is expected to grow by 8.61% on average over the next years. This is quite good.
TECH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.10% yearly.
EPS Next Y5.89%
EPS Next 2Y8.87%
EPS Next 3Y10.16%
EPS Next 5Y8.61%
Revenue Next Year1.85%
Revenue Next 2Y4.68%
Revenue Next 3Y5.76%
Revenue Next 5Y7.1%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TECH Yearly Revenue VS EstimatesTECH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
TECH Yearly EPS VS EstimatesTECH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 33.07, TECH can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 65.52% of the companies listed in the same industry.
TECH's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.37.
The Price/Forward Earnings ratio is 27.90, which means the current valuation is very expensive for TECH.
Based on the Price/Forward Earnings ratio, TECH is valued a bit cheaper than the industry average as 74.14% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.20, TECH is valued a bit cheaper.
Industry RankSector Rank
PE 33.07
Fwd PE 27.9
TECH Price Earnings VS Forward Price EarningsTECH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 65.52% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, TECH is valued a bit cheaper than 62.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF 44.38
EV/EBITDA 26.55
TECH Per share dataTECH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
TECH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.61
PEG (5Y)2.94
EPS Next 2Y8.87%
EPS Next 3Y10.16%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.50%, TECH is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.45, TECH pays a better dividend. On top of this TECH pays more dividend than 93.10% of the companies listed in the same industry.
With a Dividend Yield of 0.50, TECH pays less dividend than the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 0.5%

5.2 History

The dividend of TECH has a limited annual growth rate of 0.11%.
TECH has paid a dividend for at least 10 years, which is a reliable track record.
TECH has decreased its dividend recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
TECH Yearly Dividends per shareTECH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

TECH pays out 65.26% of its income as dividend. This is not a sustainable payout ratio.
TECH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP65.26%
EPS Next 2Y8.87%
EPS Next 3Y10.16%
TECH Yearly Income VS Free CF VS DividendTECH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
TECH Dividend Payout.TECH Dividend Payout, showing the Payout Ratio.TECH Dividend Payout.PayoutRetained Earnings

BIO-TECHNE CORP

NASDAQ:TECH (12/3/2025, 8:00:01 PM)

After market: 63.82 0 (0%)

63.82

+0.87 (+1.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-03 2026-02-03/bmo
Inst Owners103.36%
Inst Owner Change7.13%
Ins Owners0.26%
Ins Owner Change3.89%
Market Cap9.94B
Revenue(TTM)1.22B
Net Income(TTM)76.84M
Analysts81.74
Price Target70.79 (10.92%)
Short Float %5.96%
Short Ratio4.18
Dividend
Industry RankSector Rank
Dividend Yield 0.5%
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP65.26%
Div Incr Years0
Div Non Decr Years1
Ex-Date11-17 2025-11-17 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.05%
Min EPS beat(2)-2.04%
Max EPS beat(2)4.14%
EPS beat(4)3
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)5
Avg EPS beat(8)2.5%
EPS beat(12)5
Avg EPS beat(12)-1.36%
EPS beat(16)7
Avg EPS beat(16)-2.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-1.54%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)1.28%
Revenue beat(8)3
Avg Revenue beat(8)-1.11%
Revenue beat(12)3
Avg Revenue beat(12)-2.41%
Revenue beat(16)4
Avg Revenue beat(16)-2.23%
PT rev (1m)5.69%
PT rev (3m)8%
EPS NQ rev (1m)-5%
EPS NQ rev (3m)-5.79%
EPS NY rev (1m)-0.1%
EPS NY rev (3m)-0.38%
Revenue NQ rev (1m)-2.78%
Revenue NQ rev (3m)-4.22%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.47%
Valuation
Industry RankSector Rank
PE 33.07
Fwd PE 27.9
P/S 8.17
P/FCF 44.38
P/OCF 39.58
P/B 5.06
P/tB 15.62
EV/EBITDA 26.55
EPS(TTM)1.93
EY3.02%
EPS(NY)2.29
Fwd EY3.58%
FCF(TTM)1.44
FCFY2.25%
OCF(TTM)1.61
OCFY2.53%
SpS7.81
BVpS12.62
TBVpS4.09
PEG (NY)5.61
PEG (5Y)2.94
Graham Number23.41
Profitability
Industry RankSector Rank
ROA 3.04%
ROE 3.91%
ROCE 11.3%
ROIC 9.33%
ROICexc 9.93%
ROICexgc 24.48%
OM 22.13%
PM (TTM) 6.32%
GM 66.83%
FCFM 18.41%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.34
Debt/EBITDA 0.8
Cap/Depr 25.63%
Cap/Sales 2.24%
Interest Coverage 14.5
Cash Conversion 66.94%
Profit Quality 291.58%
Current Ratio 4.22
Quick Ratio 2.81
Altman-Z 12.16
F-Score5
WACC10.16%
ROIC/WACC0.92
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
EPS Next Y5.89%
EPS Next 2Y8.87%
EPS Next 3Y10.16%
EPS Next 5Y8.61%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%
Revenue Next Year1.85%
Revenue Next 2Y4.68%
Revenue Next 3Y5.76%
Revenue Next 5Y7.1%
EBIT growth 1Y-10.6%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year17.25%
EBIT Next 3Y12.9%
EBIT Next 5Y8.56%
FCF growth 1Y3.97%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-2.5%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%

BIO-TECHNE CORP / TECH FAQ

Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?

ChartMill assigns a fundamental rating of 6 / 10 to TECH.


What is the valuation status for TECH stock?

ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.


How profitable is BIO-TECHNE CORP (TECH) stock?

BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.


How financially healthy is BIO-TECHNE CORP?

The financial health rating of BIO-TECHNE CORP (TECH) is 7 / 10.


What is the expected EPS growth for BIO-TECHNE CORP (TECH) stock?

The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 5.89% in the next year.